Catriona Buick1, K Joan Murphy2, Doris Howell2, Kelly Metcalfe2. 1. Faculty of Health, York University, Health, Nursing and Environmental Studies Building, Room: 301A, 4700 Keele St, Toronto, ON, M3J 1P3, Canada. cbuick@yorku.ca. 2. Faculty of Health, York University, Health, Nursing and Environmental Studies Building, Room: 301A, 4700 Keele St, Toronto, ON, M3J 1P3, Canada.
Abstract
BACKGROUND: With the introduction of oncogenic Human Papillomavirus (HPV) testing into cervical screening there is a renewed focus on primary prevention among high-risk groups. To date, little is known about the effectiveness of this program, and the extent to which individual-level factors, such as psychosocial health and agency, may play a role. In particular, it is unclear if knowledge of one's oncogenic HPV status impacts on adherence behaviors amongst women with screening abnormalities. The purpose of this study was to identify if clinical, demographic or psychosocial factors predict non-adherence with recommended colposcopy follow-up. METHODS: This prospective pilot study included 145 women referred to a large Toronto colposcopy clinic between December, 2013 and September, 2014. Demographic, clinical and psychosocial characteristics were collected at three points in time: (1) at initial colposcopy consultation; (2) 4-6 weeks following initial consultation, and; (3) at time of follow-up appointment (within 12 months of initial consultation). RESULTS: Overall, 13% (n = 145) of the women were classified as non-adherent. Older women (OR = 0.73, p < 0.01) and those with higher-grade lesions (OR = 0.10, p < 0.01) were less likely to be non-adherent, whereas current smokers (OR = 22.46, p < 0.01) were more likely to be non-adherent. While not statistically significant, variation in rates of non-adherence amongst the various HPV status groups (untested; 15.3%, HPV positive; 5.3%, HPV negative; 6.7%) warrants further study. CONCLUSION: Findings of this study indicate that younger women, those with higher-grade lesions and current smokers were more likely to be non-adherent to recommended colposcopy follow-up. While HPV status did not reach statistical significance, the direction of this finding suggests that testing for HPV may have a positive reinforcing role on adherence to follow-up. The direction of this finding warrants further study, and potentially a practical clinical goal as HPV testing for women becomes standard of care.
BACKGROUND: With the introduction of oncogenic Human Papillomavirus (HPV) testing into cervical screening there is a renewed focus on primary prevention among high-risk groups. To date, little is known about the effectiveness of this program, and the extent to which individual-level factors, such as psychosocial health and agency, may play a role. In particular, it is unclear if knowledge of one's oncogenic HPV status impacts on adherence behaviors amongst women with screening abnormalities. The purpose of this study was to identify if clinical, demographic or psychosocial factors predict non-adherence with recommended colposcopy follow-up. METHODS: This prospective pilot study included 145 women referred to a large Toronto colposcopy clinic between December, 2013 and September, 2014. Demographic, clinical and psychosocial characteristics were collected at three points in time: (1) at initial colposcopy consultation; (2) 4-6 weeks following initial consultation, and; (3) at time of follow-up appointment (within 12 months of initial consultation). RESULTS: Overall, 13% (n = 145) of the women were classified as non-adherent. Older women (OR = 0.73, p < 0.01) and those with higher-grade lesions (OR = 0.10, p < 0.01) were less likely to be non-adherent, whereas current smokers (OR = 22.46, p < 0.01) were more likely to be non-adherent. While not statistically significant, variation in rates of non-adherence amongst the various HPV status groups (untested; 15.3%, HPV positive; 5.3%, HPV negative; 6.7%) warrants further study. CONCLUSION: Findings of this study indicate that younger women, those with higher-grade lesions and current smokers were more likely to be non-adherent to recommended colposcopy follow-up. While HPV status did not reach statistical significance, the direction of this finding suggests that testing for HPV may have a positive reinforcing role on adherence to follow-up. The direction of this finding warrants further study, and potentially a practical clinical goal as HPV testing for women becomes standard of care.
Entities:
Keywords:
Adherence behaviors; Cervical cancer screening; Cervical screening abnormalities; Colposcopy; Human papillomavirus; Psychosocial health
Authors: Linda P Engelstad; Susan Stewart; Regina Otero-Sabogal; May S Leung; Patricia I Davis; Rena J Pasick Journal: Prev Med Date: 2005 Sep-Oct Impact factor: 4.018
Authors: Meghan J Walker; Anna M Chiarelli; Julia A Knight; Lucia Mirea; Gord Glendon; Paul Ritvo Journal: Breast Date: 2013-01-10 Impact factor: 4.380
Authors: Linda A Liang; Sylke R Zeissig; Gunther Schauberger; Sophie Merzweiler; Kathrin Radde; Sabine Fischbeck; Hans Ikenberg; Maria Blettner; Stefanie J Klug Journal: BMC Womens Health Date: 2022-07-09 Impact factor: 2.742
Authors: Irena Ilic; Goran Babic; Aleksandra Dimitrijevic; Sandra Sipetic Grujicic; Milena D Ilic Journal: Cancer Med Date: 2022-03-24 Impact factor: 4.711